Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPR with Galactose in Hepatic Resection
NCT01882218Phase 4Withdrawn
- Sponsor
- University of Louisville
- Start
- Sep 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of D-galactose in hepatocellular carcinoma (HCC) and colorectal cancer (CRC) (2 arms), sponsored by University of Louisville. Primary endpoint: Morbidity at 6 months. Planned start Sep 2012; status: withdrawn.
02
Drugs
D-galactose
03
Conditions
hepatocellular carcinoma (HCC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01882218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01882218.